SCHEMBL23625147

SCHEMBL23625147

CC(C)c1ccc2c(-c3ccccc3C(=O)O)c3ccc(=O)cc-3oc2c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 5/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
POLB P06746 3/20 0.51
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
ATM Q13315 2/20 0.51
PLEC Q15149 1/20 0.51
ALPL P05186 1/20 0.48
ALPI P09923 1/20 0.48
ALPG P10696 1/20 0.48
FTO Q9C0B1 2/20 0.47
DNASE1L3 Q13609 1/20 0.46
PRMT1 Q99873 1/20 0.46
KDM4E B2RXH2 2/20 0.45
ABCB1 P08183 1/20 0.45
SOS1 Q07889 1/20 0.44
CA9 Q16790 6/20 0.44
CA1 P00915 5/20 0.44
CA2 P00918 5/20 0.44
IKBKE Q14164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12637546 0.86 USP2 (0.57) USP2L3MBTL1POLBMEN1KMT2A
SCHEMBL12637647 0.86 USP2 (0.72) USP2L3MBTL1POLBMEN1KMT2A
SCHEMBL10060277 0.85 POLB (0.59) USP2L3MBTL1POLBMEN1KMT2A
SCHEMBL18932154 0.85 USP2 (0.56) USP2L3MBTL1POLBMEN1KMT2A
SCHEMBL16231516 0.85 USP2 (0.64) USP2L3MBTL1POLBMEN1KMT2A
SCHEMBL17549805 0.85 USP2 (0.51) USP2L3MBTL1POLBMEN1KMT2A
SCHEMBL107875 0.84 USP2 (0.76) USP2L3MBTL1POLBMEN1KMT2A
SCHEMBL29781098 0.84 USP2 (0.76) USP2L3MBTL1POLBMEN1KMT2A
SCHEMBL29591827 0.84 USP2 (0.76) USP2L3MBTL1POLBMEN1KMT2A
SCHEMBL8947940 0.84 USP2 (0.58) USP2L3MBTL1POLBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210206791-A1 SELECTIVE METAL-MEDIATED ARYLATION OF DICHALCOGENIDES IN BIOMOLECULES MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2021-07-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210206791-A1 SELECTIVE METAL-MEDIATED ARYLATION OF DICHALCOGENIDES IN BIOMOLECULES SCLY, SELENOI, PTMS USP2 972/4885L3MBTL1 2229/4885POLB 3413/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.